chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion
Clinical narrative: some body feeling sick last night at around nine p. m; fever; two eighty excruciating pain in my head and my face; two eighty excruciating pain in my head and my face; i'm sweating; my face my eyes are dilated; my face my eyes are dilated; I have had aches everywhere; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: izrfe3180, expiration date was not reported), via an unspecified route of administration on 18Aug2021 (at the age of 47-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got the vaccine yesterday the first dose and somebody feeling sick last night on 18Aug2021 at around nine p. m. fever of a hundred and two eighty excruciating pain in her head and her face her eyes are dilated she was sweating and she had aches everywhere. The patient underwent lab tests and procedures which included fever (body temperature): hundred on 18Aug2021, pain (pain assessment): two eighty on 18Aug2021. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Facial pain, Headache, Hyperhidrosis, Illness
Clinical narrative: some body feeling sick last night at around nine p. m; fever; two eighty excruciating pain in my head and my face; two eighty excruciating pain in my head and my face; i'm sweating; my face my eyes are dilated; my face my eyes are dilated; I have had aches everywhere; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: izrfe3180, expiration date was not reported), via an unspecified route of administration on 18Aug2021 (at the age of 47-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got the vaccine yesterday the first dose and somebody feeling sick last night on 18Aug2021 at around nine p. m. fever of a hundred and two eighty excruciating pain in her head and her face her eyes are dilated she was sweating and she had aches everywhere. The patient underwent lab tests and procedures which included fever (body temperature): hundred on 18Aug2021, pain (pain assessment): two eighty on 18Aug2021. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mydriasis, Pain, Pain assessment, Pyrexia, Swelling face
Clinical narrative: some body feeling sick last night at around nine p. m; fever; two eighty excruciating pain in my head and my face; two eighty excruciating pain in my head and my face; i'm sweating; my face my eyes are dilated; my face my eyes are dilated; I have had aches everywhere; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: izrfe3180, expiration date was not reported), via an unspecified route of administration on 18Aug2021 (at the age of 47-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got the vaccine yesterday the first dose and somebody feeling sick last night on 18Aug2021 at around nine p. m. fever of a hundred and two eighty excruciating pain in her head and her face her eyes are dilated she was sweating and she had aches everywhere. The patient underwent lab tests and procedures which included fever (body temperature): hundred on 18Aug2021, pain (pain assessment): two eighty on 18Aug2021. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: pt presented to ED with SOB and cough, unable to care for self; hx of AKI, DMT2, CVA, HTN; tested positive for COVID; acute respiratory failure with hypoxia; fluid build up in lungs; requiring 100% Vapotherm consistently with decompensation; pt's condition began to deteriorate; body began to shut down; discharged to hospice where she passed away
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Cough, Death, Dyspnoea
Clinical narrative: pt presented to ED with SOB and cough, unable to care for self; hx of AKI, DMT2, CVA, HTN; tested positive for COVID; acute respiratory failure with hypoxia; fluid build up in lungs; requiring 100% Vapotherm consistently with decompensation; pt's condition began to deteriorate; body began to shut down; discharged to hospice where she passed away
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: General physical health deterioration, Impaired self-care, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: pt presented to ED with SOB and cough, unable to care for self; hx of AKI, DMT2, CVA, HTN; tested positive for COVID; acute respiratory failure with hypoxia; fluid build up in lungs; requiring 100% Vapotherm consistently with decompensation; pt's condition began to deteriorate; body began to shut down; discharged to hospice where she passed away
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest pain, Fall, Hyperhidrosis, Loss of consciousness
Clinical narrative: Had a BP of 280/140; Eyes totally dilated; unconscious for roughly 5 mins; collapsed on the floor of the pharmacy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT62B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 03Aug2021, after the shot, patient waited 15 mins. Patient collapsed on the floor of the pharmacy. Patient was unconscious for roughly 5 mins, had a BP of 280/140, eyes totally dilated. After regaining consciousness, patient left. Patient saw the doctor who said not to get the 2nd shot. Patient's fiance arrived at the pharmacy to get the shot and waited for patient were execs from Pfizer wanting to speak. Patient have since had hospital tests and was hoping to hear from Pfizer. Outcome of 'unconscious for roughly 5 mins' was recovered on 03Aug2021, outcome of remaining events was unknown.   .
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Mydriasis, Pallor
Clinical narrative: Had a BP of 280/140; Eyes totally dilated; unconscious for roughly 5 mins; collapsed on the floor of the pharmacy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT62B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 03Aug2021, after the shot, patient waited 15 mins. Patient collapsed on the floor of the pharmacy. Patient was unconscious for roughly 5 mins, had a BP of 280/140, eyes totally dilated. After regaining consciousness, patient left. Patient saw the doctor who said not to get the 2nd shot. Patient's fiance arrived at the pharmacy to get the shot and waited for patient were execs from Pfizer wanting to speak. Patient have since had hospital tests and was hoping to hear from Pfizer. Outcome of 'unconscious for roughly 5 mins' was recovered on 03Aug2021, outcome of remaining events was unknown.   .
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Fall, Hypertension, Laboratory test, Loss of consciousness
Clinical narrative: Had a BP of 280/140; Eyes totally dilated; unconscious for roughly 5 mins; collapsed on the floor of the pharmacy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT62B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 03Aug2021, after the shot, patient waited 15 mins. Patient collapsed on the floor of the pharmacy. Patient was unconscious for roughly 5 mins, had a BP of 280/140, eyes totally dilated. After regaining consciousness, patient left. Patient saw the doctor who said not to get the 2nd shot. Patient's fiance arrived at the pharmacy to get the shot and waited for patient were execs from Pfizer wanting to speak. Patient have since had hospital tests and was hoping to hear from Pfizer. Outcome of 'unconscious for roughly 5 mins' was recovered on 03Aug2021, outcome of remaining events was unknown.   .
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Mydriasis
Clinical narrative: Had a BP of 280/140; Eyes totally dilated; unconscious for roughly 5 mins; collapsed on the floor of the pharmacy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT62B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 03Aug2021, after the shot, patient waited 15 mins. Patient collapsed on the floor of the pharmacy. Patient was unconscious for roughly 5 mins, had a BP of 280/140, eyes totally dilated. After regaining consciousness, patient left. Patient saw the doctor who said not to get the 2nd shot. Patient's fiance arrived at the pharmacy to get the shot and waited for patient were execs from Pfizer wanting to speak. Patient have since had hospital tests and was hoping to hear from Pfizer. Outcome of 'unconscious for roughly 5 mins' was recovered on 03Aug2021, outcome of remaining events was unknown.   .
Age: 61.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blood test, Computerised tomogram, Echocardiogram, Ischaemic stroke, Magnetic resonance imaging
Clinical narrative: Lightheadedness; Ischemic Stroke with paralysis (on his left side); Ischemic Stroke with paralysis (on his left side); This case was reported by a consumer via call center representative and described the occurrence of ischemic stroke in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number 52b24, expiry date unknown) for prophylaxis.   Previously administered products included Moderna Covid vaccine (received 6 months prior to Shingrix).   On 26th July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 26th July 2021, 2 hrs after receiving Shingrix, the patient experienced ischemic stroke (serious criteria GSK medically significant) and left sided paralysis (serious criteria GSK medically significant). On an unknown date, the patient experienced light headedness. On an unknown date, the outcome of the ischemic stroke and left sided paralysis were recovered/resolved and the outcome of the light headedness was not recovered/not resolved.   It was unknown if the reporter considered the ischemic stroke, left sided paralysis and light headedness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient received 1st dose of Shingrix in his left deltoid at his local pharmacy and two hours after vaccination, the patient experienced a left-sided ischemic stroke with paralysis.  The patient reported that he had made a rapid recovery from the stroke and that the only remaining symptom he still sometimes experienced was lightheadedness.  The patient's doctor still wanted him to get the second dose of the Shingrix, but the patient was afraid to do so.  The patient reported that he was not certain that the stroke was related to the Shingrix vaccine and that it might had just been coincidental. The patient did not have the expiration date of the Shingrix vaccine he was given. The reporter consented to follow up.
Age: 61.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Scan with contrast
Clinical narrative: Lightheadedness; Ischemic Stroke with paralysis (on his left side); Ischemic Stroke with paralysis (on his left side); This case was reported by a consumer via call center representative and described the occurrence of ischemic stroke in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number 52b24, expiry date unknown) for prophylaxis.   Previously administered products included Moderna Covid vaccine (received 6 months prior to Shingrix).   On 26th July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 26th July 2021, 2 hrs after receiving Shingrix, the patient experienced ischemic stroke (serious criteria GSK medically significant) and left sided paralysis (serious criteria GSK medically significant). On an unknown date, the patient experienced light headedness. On an unknown date, the outcome of the ischemic stroke and left sided paralysis were recovered/resolved and the outcome of the light headedness was not recovered/not resolved.   It was unknown if the reporter considered the ischemic stroke, left sided paralysis and light headedness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient received 1st dose of Shingrix in his left deltoid at his local pharmacy and two hours after vaccination, the patient experienced a left-sided ischemic stroke with paralysis.  The patient reported that he had made a rapid recovery from the stroke and that the only remaining symptom he still sometimes experienced was lightheadedness.  The patient's doctor still wanted him to get the second dose of the Shingrix, but the patient was afraid to do so.  The patient reported that he was not certain that the stroke was related to the Shingrix vaccine and that it might had just been coincidental. The patient did not have the expiration date of the Shingrix vaccine he was given. The reporter consented to follow up.
Age: 61.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Dizziness, Hemiplegia, Ischaemic stroke
Clinical narrative: Lightheadedness; Ischemic Stroke with paralysis (on his left side); Ischemic Stroke with paralysis (on his left side); This case was reported by a consumer via call center representative and described the occurrence of ischemic stroke in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number 52b24, expiry date unknown) for prophylaxis.   Previously administered products included Moderna Covid vaccine (received 6 months prior to Shingrix).   On 26th July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 26th July 2021, 2 hrs after receiving Shingrix, the patient experienced ischemic stroke (serious criteria GSK medically significant) and left sided paralysis (serious criteria GSK medically significant). On an unknown date, the patient experienced light headedness. On an unknown date, the outcome of the ischemic stroke and left sided paralysis were recovered/resolved and the outcome of the light headedness was not recovered/not resolved.   It was unknown if the reporter considered the ischemic stroke, left sided paralysis and light headedness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient received 1st dose of Shingrix in his left deltoid at his local pharmacy and two hours after vaccination, the patient experienced a left-sided ischemic stroke with paralysis.  The patient reported that he had made a rapid recovery from the stroke and that the only remaining symptom he still sometimes experienced was lightheadedness.  The patient's doctor still wanted him to get the second dose of the Shingrix, but the patient was afraid to do so.  The patient reported that he was not certain that the stroke was related to the Shingrix vaccine and that it might had just been coincidental. The patient did not have the expiration date of the Shingrix vaccine he was given. The reporter consented to follow up.
Age: 7.0
Sex: F
Vaccine: IPV, VARCEL, IPV, VARCEL
Symptoms: Bell's palsy, Facial paralysis, Facial paresis
Clinical narrative: Patient had focal papular rash on chin 1 week after receiving IPV vaccine on 8/19/2021. Her five month old sister subsequently developed suspected chicken pox 1 week later. Suspected case of breakthrough case of chicken pox after live vaccine which than infected younger sister.
Age: 7.0
Sex: F
Vaccine: IPV, VARCEL, IPV, VARCEL
Symptoms: Facial paralysis, Rash papular, Vaccine breakthrough infection, Varicella
Clinical narrative: Patient had focal papular rash on chin 1 week after receiving IPV vaccine on 8/19/2021. Her five month old sister subsequently developed suspected chicken pox 1 week later. Suspected case of breakthrough case of chicken pox after live vaccine which than infected younger sister.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Dizziness, Gastrointestinal disorder, Gastrooesophageal reflux disease
Clinical narrative: diarrhea; nausea; lightheaded; acid reflux; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included COVID virus in Nov2020. The patient's concomitant medications were not reported. The patient experienced diarrhea, nausea, lightheaded and acid reflux on an unspecified date in Feb2021 since getting the first vaccine and is still experiencing side effects. She was asking if she should get the second dose. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb injury, Malaise, Nausea, SARS-CoV-2 test
Clinical narrative: diarrhea; nausea; lightheaded; acid reflux; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included COVID virus in Nov2020. The patient's concomitant medications were not reported. The patient experienced diarrhea, nausea, lightheaded and acid reflux on an unspecified date in Feb2021 since getting the first vaccine and is still experiencing side effects. She was asking if she should get the second dose. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Gastrooesophageal reflux disease, Nausea
Clinical narrative: diarrhea; nausea; lightheaded; acid reflux; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included COVID virus in Nov2020. The patient's concomitant medications were not reported. The patient experienced diarrhea, nausea, lightheaded and acid reflux on an unspecified date in Feb2021 since getting the first vaccine and is still experiencing side effects. She was asking if she should get the second dose. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging thoracic, Neurological eyelid disorder, Pulmonary function test, SARS-CoV-2 test, Scan brain
Clinical narrative: have neurologic distress in the right eye, he can see but cannot blink or wink, and all the muscles from his eyebrow, side temple, and cheek portion are in neurological distress; he could maintain his eye open halfway; This is a spontaneous report from a Contactable consumer via medical information team.  A 77-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot: not reported), via unspecified route of administration on unspecified date as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications not reported. patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot: not reported), via unspecified route of administration on unspecified date as a dose 1, single for COVID-19 immunization. It was reported that patient received both doses of the Pfizer Covid-19 vaccine of the Pfizer Covid-19 vaccine and within 30 days after the second dose started to have neurologic distress in the right eye, he can see but cannot blink or wink, and all the muscles from his eyebrow, side temple, and cheek portion are in neurological distress on an unspecified date. Reporter stated that eventually as it started to wear off, he could maintain his eye open halfway on an unspecified date. Stated that his health care professional (HCP) referred him to a neurologist and had a brain scan, MRI of chest, and pulmonary exam performed and all were normal. Reporter stated that the only way to keep his eye open was his HCP prescribed him tyridostigmine bromide 60 MG TABS twice a day to keep eye open. Reporter queried for if anyone else has reported the same above complaints as her employer with the Pfizer Covid-19 vaccine. Pfizer-BioNTech COVID-19 Vaccine group. Onset of facial paralysis was Day 37 after Dose 1 (participant did not receive Dose 2) and Days 3, 9, and 48 after Dose 2. Outcome of events was unknown.  This lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye movement disorder, Magnetic resonance imaging, Neurological symptom, Pulmonary function test, Scan brain
Clinical narrative: have neurologic distress in the right eye, he can see but cannot blink or wink, and all the muscles from his eyebrow, side temple, and cheek portion are in neurological distress; he could maintain his eye open halfway; This is a spontaneous report from a Contactable consumer via medical information team.  A 77-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot: not reported), via unspecified route of administration on unspecified date as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications not reported. patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot: not reported), via unspecified route of administration on unspecified date as a dose 1, single for COVID-19 immunization. It was reported that patient received both doses of the Pfizer Covid-19 vaccine of the Pfizer Covid-19 vaccine and within 30 days after the second dose started to have neurologic distress in the right eye, he can see but cannot blink or wink, and all the muscles from his eyebrow, side temple, and cheek portion are in neurological distress on an unspecified date. Reporter stated that eventually as it started to wear off, he could maintain his eye open halfway on an unspecified date. Stated that his health care professional (HCP) referred him to a neurologist and had a brain scan, MRI of chest, and pulmonary exam performed and all were normal. Reporter stated that the only way to keep his eye open was his HCP prescribed him tyridostigmine bromide 60 MG TABS twice a day to keep eye open. Reporter queried for if anyone else has reported the same above complaints as her employer with the Pfizer Covid-19 vaccine. Pfizer-BioNTech COVID-19 Vaccine group. Onset of facial paralysis was Day 37 after Dose 1 (participant did not receive Dose 2) and Days 3, 9, and 48 after Dose 2. Outcome of events was unknown.  This lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Myocarditis
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Inflammation, Insomnia, Investigation, Movement disorder
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Musculoskeletal chest pain, Pneumonia bacterial, Pulmonary oedema, Pulmonary pain
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Aspiration pleural cavity, Blood pressure diastolic abnormal, Computerised tomogram, Inflammation
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Laboratory test abnormal, Loss of employment, Musculoskeletal chest pain, Myocarditis, Pneumonia bacterial
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pneumonitis, Pulmonary pain, Suspected COVID-19, X-ray
Clinical narrative: huge inflammation around heart, lungs and ribs; lot of water around the lungs; it has developed some bacterial pneumonia; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; there was a tremendous pain on my heart, lungs and ribs; the reaction was so tough that I could not even move at all; could not even sleep; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received third dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 20Sep2021 (Batch/Lot number was not reported) (vaccinated at 60-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included diabetes and hypertension. Patient received first and second dose of bnt162b2 on an unspecified date. Patient's concomitant medications included unspecified diabetes medications and hypertension medications. Patient was talking about third dose of Covid-19 vaccine. He took the vaccine on 20th of last month and on 21st he was going to while on a reaction have to hospitalized from 21Sep2021 to 28Sep2021 for 8 days because of a huge inflammation around heart, lungs and ribs. And subsequently found lot of water also around the lungs. There was reaction of the vaccine on 21st last month. The reaction was so tough that could not even move at all and there was a tremendous pain on heart, lungs and ribs and then hospitalized in emergency and for first four days even with the Morphine injection (captured as suspect) and there was an opioid injection like Hydrocodone, pain could not be in control eventually and was grieving day and night that could not even sleep but later on they found that water has risen up around lungs so they drilled back and remove some water and then was feeling comfortable. They also found that it has developed some bacterial pneumonia. Patient was hospitalized for 8 days and now on antibiotics (treatment) at home, taking rest for two months. Lab work on an unspecified date with unknown results. The outcome of events was unknown.  The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Hypoaesthesia, Neuropathy peripheral, Paraesthesia
Clinical narrative: neuropathy symptoms; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced neuropathy symptoms on an unspecified date with outcome of unknown. The patient had seen the neurologist and they can find no causes. The patient was notifying Pfizer as he/she felt it could be connected to the vaccine.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: neuropathy symptoms; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced neuropathy symptoms on an unspecified date with outcome of unknown. The patient had seen the neurologist and they can find no causes. The patient was notifying Pfizer as he/she felt it could be connected to the vaccine.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood test, Dizziness, Endoscopy, Feeling abnormal
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging, Migraine, Neck pain, Nystagmus
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Tinnitus, Vertigo
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.